DATA ANALYSIS
• All analyses will be based on the entire enrolled population using an observed case approach • Data will be summarized using descriptive statistics • Cumulative incidence and incidence rates of prospective events will be calculated -Patients lost to follow-up will have their person-time contribution to the registry included in the analyses • As the database grows, protocol-driven specific research questions and hypothesis testing will be done
SCIENTIFIC STEERING COMMITTEE
• Steering committee composed of 9 members (6 independent medical experts, 3 representatives of the study sponsor) -Membership is currently based in the United States, but will be expanded internationally within the year -Independent medical experts are all physicians involved in both clinical practice and research • Provides scientific guidance and oversight • Advises on ethical policy decisions • Develops and/or approves proposed research projects • Evaluates all requests for analyses and publications • Coordinates the formation of and provides the oversight for research topic working groups • Coordinates and guides publications and presentations
CONCLUSIONS
• PARADIGHM™ will provide previously unavailable longterm, prospective data from a large sample of patients with chronic hypoparathyroidism
• Physicians' contributions of patient data to PARADIGHM™ will benefit all registry participants, since data are pooled to study trends or address specific questions
• The hypoparathyroidism community will gain important information on a rare condition that affects a small patient population, and its treatment REGISTRY PARTICIPATION 
PARADIGHM™ STUDY DESIGN
• Patients will be enrolled at participating study centers -Approximately 7 years of patient recruitment -Global target enrollment is 900 patients -Estimated study completion date: June 2032 -ClinicalTrials.gov identifier: NCT01922440 -Follow-up for each patient will be a minimum of 10 years • Patient care and follow-up will be according to routine care by the patients' physicians -Except for patient questionnaires, no study-defined procedures will be required
